The AS/AGU rat: A spontaneous model of disruption and degeneration in the nigrostriatal dopaminergic system

Journal of Anatomy

Volumn 196, Issue 4, 2000, Pages 629-633

  Payne, A P ^a   Campbell, J M ^a   Russell, D ^a   Favor, G ^a   Sutcliffe, R G ^a   Bennett, N K ^a   Davies, R W ^a   Stone, T W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

AS AGU rat; Nigrostriatal dopaminergic system

Indexed keywords

DOPAMINE; GLUCOSE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL GANGLION; CAUDATE NUCLEUS; CONTROLLED STUDY; DISEASE MODEL; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EXTRAPYRAMIDAL SYNDROME; GLUCOSE UTILIZATION; MOTOR DYSFUNCTION; MOUSE STRAIN; MUTANT; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; REVIEW; RIGIDITY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS VENTRAL NUCLEUS; TREMOR;

ANIMALS; BASAL GANGLIA DISEASES; DISEASE MODELS, ANIMAL; DOPAMINE; GENES, RECESSIVE; LEVODOPA; RATS; RATS, MUTANT STRAINS;

EID: 0033925580     PISSN: 00218782     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-7580.2000.19640629.x     Document Type: Review

References (22)

1. BANDMANN O, MARSDEN CD, WOOD NW (1998) Genetic aspects of Parkinson's disease. Movement Disorders 13, 203-211.
2. BERMAN SB, ZIGMOND MJ, HASTINGS TG (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. Journal of Neurochemistry 67, 593-600.
3. BEZARD H, IMBERT C, GROSS CE (1998) Experimental models of Parkinson's disease: from the static to the dynamic. Reviews in the Neurosciences 9, 71-90.
4. CAMPBELL JM, TSANG C, WEIR J, SUTCLIFFE RG, DAVIES RW, RUSSELL DA et al. (1997) The effects of L-DOPA replacement on locomotion in the AS/AGU mutant rat. Society for Neuroscience Abstracts 23, 1899.
5. CAMPBELL JM, PAYNE AP, GILMORE DP, RUSSELL D, McGADEY J et al. (1996) Neostriatal dopamine depletion and locomotor abnormalities due to the albino Swiss rat agu mutation. Neuroscience Letters 213, 173-176.
6. CAMPBELL JM. PAYNE AP, GILMORE DP, RUSSELL D, McGADEY J, CLARKE DJ et al. (1997) Age changes in dopamine levels in the corpus striatum of Albino Swiss (AS) and AS/AGU mutant rats. Neuroscience Letters 238, 1-3.
7. CAMPBELL JM, FAVOR G, RUSSELL D, BENNETT NK, STONE TW, DAVIES RW et al. (1998a) A microdialysis study of evoked dopamine release and re-uptake blockade in the AS/AGU rat. Society for Neuroscience Abstracts 24, 1949
8. CAMPBELL JM, GILLMORE DP, RUSSELL D, GROWNEY CA, FAVOR G, WEIR J et al. (1998b) Microdialytic studies of dopamine and its metabolites in the corpus striatum of conscious AS/AGU mutant rats. Neuroscience 85, 323-325.
9. CLARKE DJ, PAYNE AP (1994) Neuroanatomical characterisation of a new mutant rat with dopamine depletion in the substantia nigra. European Journal of Neuroscience 6, 885-888.
10. COHEN G, FAROOQUI R, KESLER N (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial election flow. Proceedings of the National Academy of Sciences of the USA 94, 4890-4894.
11. GRAHAM DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Molecular Pharmacology 14, 633-643.
12. GASSER T (1998) Genetics of Parkinson's disease. Clinical Genetics 54, 259-265.
13. GIBB WRG (1993) The neuropathology of Parkinsonian disorders. In Parkinson's Disease and Movement Disorders, 2nd edn (ed. Jankovic J, Tolosa E), pp. 253-270. Baltimore: Williams and Wilkins.
14. GRAFTON ST, MAZZIOTTA JC, PAHL JJ, ST. GEORGE-HYSLOP P, HAINES JL, GUSELLA J et al. (1992) A comparison of neurological, metabolic, structural and genetic evaluations in persons at risk for Huntington's disease. Annals of Neurology 28, 614-621.
15. HASTINGS TG, LEWIS DA, ZIGMOND MJ (1996) Reactive dopaminc metabolites and neurotoxicity. Advances in Experimental Medicine and Biology 387, 97-106.
16. JENNER P, MARSDEN CD (1993) MPTP-induced Parkinsonism : a model of Parkinson's disease and its relevance to the disease process. In Parkinson's Disease and Movement Disorders (ed. Jankovic J, Tolosa E), pp. 55-75. Baltimore: Williams & Wilkins.
17. LAM AGM, CAMPBELL JM, BENNETT NK, PAYNE AP, DAVIES RW, SUTCLIFFE RG et al. (1998) Local cerebral glucose utilisation in the AS/AGU rat : a mutant with movement disorders. European Journal of Neuroscience 10, 1963-1967.
18. LEENDERS KL, SALMON EP, TYRRELL P, PERANI D, BROOKS DJ, SAGER H et al. (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Archives of Neurology 41, 1290-1298.
19. PAYNE AP, SUTCLIFFE RG, CAMPBELL JM, FAVOR G, RUSSELL D, BENNETT NK et al. (1998) Disordered locomotion in the AS/AGU mutant rat and the effects of L-DOPA or fetal midbrain grafts. Movement Disorders 13, 832-834.
20. RUSSELL D, CAMPBELL JM, FAVOR G, NEILSSON M, BENNETT NK, SUTCLlFFE RG et al. (1998) Locomotion in the AS/AGU mutant rat: progressive deficits and the effects of L-DOPA replacement. Society for Neuroscience Abstracts 24, 1718
21. SHIELS P, DURAN ALONSO MB, DAVIDSON AO, HEELEY RP, DOMINICZAK AF, PAYNE AP et al. (1995) Optimized protocols for typing 75 microsatellite loci in AS, PVG, F344 and BN rats. Mammalian Genome 6, 214-215.
22. STOKES AH, HASTINGS TG, VRANA KE (1999) Cytotoxic and genotoxic potential of dopamine. Journal of Neuroscience Research 55, 659-665.